PAS
DNA icon

Point72 Asia (Singapore)’s Ginkgo Bioworks DNA Stock Holding History

Point72 Asia (Singapore)’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-56,078
Closed -$320K – 974
2025
Q1 		$320K Buy
56,078
+31,260
+126% +$318K 0.08% 191
2024
Q4 		$244K Sell
24,818
-7,501
-23% -$64.3K 0.06% 216
2024
Q3 		$263K Buy
32,319
+32,210
+29,550% +$323K 0.05% 311
2024
Q2 		$1.45K Sell
109
-761
-87% -$22.7K ﹤0.01% 997
2024
Q1 		$40.4K Buy
+870
New +$45K 0.01% 838

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return